サマリー

eClinical Solutions市場の成長と傾向

Grand View Research, Inc.の最新レポートによると、世界のeClinicalソリューション市場規模は、2030年までに218億米ドルに達する見込みです。この市場は、2022年から2030年にかけて13.6%のCAGRで拡大すると予測されています。バイオファーマや製薬会社による研究開発活動の活発化、臨床試験におけるソフトウェアソリューションの適用、顧客層の拡大などが市場の成長を促進すると予想されます。COVID-19が大流行した際、臨床検査室ではCOVID-19検査の需要が高まりました。臨床データ管理システムなどのeClinicalソリューションは、これらの検査室が日々流入する大量の検体をシームレスに管理するのに役立ちました。電子データ収集やWi-Fi接続などの技術的進歩が、今後数年間の市場を牽引すると予測されています。

臨床データの追跡・分析に対する需要が高まるにつれ、効果的な臨床ソリューションの必要性が高まっています。効率的な臨床開発プロセスを管理したいという満たされていないニーズが、予測期間中の市場成長を後押しすると考えられます。さらに、臨床試験分野におけるデジタルトランスフォーメーションと、データ中心のアプローチへの嗜好が、市場を大きく後押ししています。臨床開発プロセスでは大量のデータが生成されるため、統合型の臨床ITソリューションに対する需要が高まっています。eClinicalソリューションは、単一の情報源を提供することで、重複したデータ入力を排除し、現場での検証やソースデータの確認を減らすことで、コストの最適化に貢献します。このような利点に対する認識の高まりが、市場を促進すると予測されます。

臨床試験におけるeClinicalワークフローの採用が増加しており、臨床開発プロセスにおいて大きな可能性を秘めています。これらのソリューションは、開発の各段階における意思決定を促進します。また、シームレスデザインを活用したり、失敗した化合物を特定したりすることで、開発段階のコストと時間を削減することができます。さらに、データや患者の安全性に関する情報に迅速にアクセスできるため、迅速な意思決定にも役立ちます。市場のプレーヤーは、新製品の開発やパートナーシップ契約を含む戦略的提携、プロモーション活動、買収などを行い、市場の競争力を高めています。例えば、2020年10月、オラクルは、臨床試験の効率化と治療薬の早期市場投入のために、FHI Clinical Inc.と提携しました。

eクリニカルソリューション市場レポートのハイライト

- CTMSは、臨床試験活動のエンドツーエンドの集中管理、手動プロセスへの依存の排除、リアルタイムのステータス追跡、複数のデータベースの維持などのメリットがあり、臨床試験の全体的な効率を向上させることができるため、2021年に製品セグメントをリードし、約21%の収益シェアを占めました。

- クラウドベースのシステムは、柔軟性、高いアクセス性、最小限の処理コスト、容易なデータバックアップなどの機能を備えているため、予測期間中に15.1％の急激な成長が見込まれています。これらのシステムでは、リアルタイムのデータが得られるため、ユーザーは迅速な意思決定が可能となり、リスクベースのモニタリングに必要な高品質の情報を提供することができます。

- 2021年の市場では、CROのセグメントが最大の収益シェアを占めています。このセグメントは、製薬会社が総支出を削減する傾向にあることから、予測期間中に13.9%の顕著なCAGRで増加すると予測されています。

- 主要企業は、市場シェアを拡大するために、M&Aや新製品の開発など、さまざまなビジネス戦略に取り組んでいる

ページTOPに戻る

目次

Table of Contents

Chapter 1. Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates & Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Region specific data for primary interviews
1.3.5.1.1 North America
1.3.5.1.2 Europe
1.3.5.1.3 Asia Pacific
1.3.5.1.4 Central & South America
1.3.5.1.5 MEA
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Total Addressable market Analysis (Model 2)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.11 Market Definitions
Chapter 2. Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Outlook
Chapter 3. eClinical Solution Market Variables Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration & Growth Prospect Mapping By Delivery Mode, 2021
3.3 Pricing Analysis
3.3.1 By Product
3.3.1.1 eCOA
3.3.1.2 EDC & CDMS
3.3.1.3 Clinical Analytics Platforms
3.3.1.4 Clinical data integration platforms
3.3.1.5 Safety solutions
3.3.1.6 CTMS
3.3.1.7 RTSM
3.3.1.8 eTMF
3.3.2 BY Delivery mode
3.3.3 by Development phase
3.4 User Perspective Analysis
3.4.1 Market influencer analysis
3.5 List of Key End Users
3.6 Technology Overview
3.6.1 EClinical Solutions changing technology & adoption
3.7 Regulatory Framework
3.7.1 Regulatory Landscape
3.7.1.1 List of regulations, by country
3.8 Market Dynamics
3.8.1 Market Driver Analysis
3.8.1.1 Increasing externalization of clinical trial studies by large pharmaceutical and biopharmaceutical companies
3.8.1.2 Advantages of eClinical solutions
3.8.1.3 Presence of strong range of products in pipeline
3.8.2 Market Restraints Analysis
3.8.2.1 Scarcity of skilled research professionals
3.8.2.2 Lack of recognition
3.8.3 Industry challenges
3.9 Industry Analysis - Porter’s
3.10 eClinical Solutions - SWOT Analysis, by Factor (Political & Legal, Economic, Social and Technological)
Chapter 4. COVID-19 Impact Analysis
4.1 COVID-19 Outbreak
4.2 Impact on Ongoing Clinical Trials
4.2.1 Obstacles in clinical trials:
4.2.2 Disrupted clinical trials
4.3 Demand Analysis
4.3.1 Product Pipeline Analysis, by Stage for COVID-19
4.4 Virtual Clinical Trials
4.5 Recent Developments & Strategic Outcomes
4.5.1 Strategies implemented by companies
4.5.1.1 Oracle
4.5.1.2 PARAXEL International Corporation
4.5.1.3 Bioclinica
4.5.1.4 Datatrak International, Inc.
4.5.1.5 Medidata Solution, Inc.
4.5.1.6 ERT Clinical
4.5.1.7 eClinicalWorks
4.5.1.8 IBM Watson Health
4.5.1.9 eClinical Solutions
4.5.1.10 Veeva Systems
4.5.1.11 Elsevier
4.5.1.12 IQVIA
4.5.1.13 Pharmaceutical Product Development (PPD)
4.5.1.14 ICON, plc
4.5.1.15 PRA Health Sciences
4.5.1.16 Covance Inc
Chapter 5. eClinical Solutions Market: Competitive Analysis
5.1 Market Participation Categorization
5.2 Public Companies
5.2.1 Company market position analysis
5.3 Company Market Share Analysis
5.3.1 eClinical solutions estimated company market share analysis, 2021
5.4 Competitive & Vendor Landscape
5.4.1 List of key strategies, by company
5.4.2 Market leader
5.4.3 Innovators
5.4.4 Vendor Landscape
5.4.4.1 List of eClinical service providers
Chapter 6. eClinical Solutions Market: Product Analysis
6.1 Product Business Analysis
6.1.1 Electronic clinical outcome assessment (ECOA)
6.1.1.1 ECOA market estimates and forecasts, 2017 - 2030 (USD Million)
6.1.2 Electronic data capture (EDC) & clinical data management systems (CDMS)
6.1.2.1 EDC & CDMS market estimates and forecasts, 2017 - 2030 (USD Million)
6.1.3 Clinical analytics platform
6.1.3.1 clinical analytics platform market estimates and forecasts, 2017 - 2030 (USD Million)
6.1.4 Clinical data integration platform
6.1.4.1 Clinical data integration platform market estimates and forecasts, 2017 - 2030 (USD Million)
6.1.5 Safety solutions
6.1.5.1 Safety solutions market estimates and forecasts, 2017 - 2030 (USD Million)
6.1.6 Clinical trial management systems (CTMS)
6.1.6.1 CTMS market estimates and forecasts, 2017 - 2030 (USD Million)
6.1.7 Randomization and trial supply management (RTSM)
6.1.7.1 RTSM market estimates and forecasts, 2017 - 2030 (USD Million)
6.1.8 Electronic trial master file (eTMF)
6.1.8.1 eTMF market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 7. eClinical Solutions Market : Delivery Mode Analysis
7.1 Delivery Mode Business Analysis
7.1.1 Web-hosted
7.1.2 Web-hosted market estimates and forecasts, 2017 - 2030 (USD Million)
7.1.3 Licensed Enterprise
7.1.4 Licensed enterprise market estimates and forecasts, 2017 - 2030 (USD Million)
7.1.5 Cloud-based
7.1.5.1 Cloud based market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 8. eClinical Solutions Market : Development Phase Analysis
8.1 Development Phase Business Analysis
8.2 Phase I
8.2.1 Phase I market estimates and forecasts, 2017 - 2030 (USD Million)
8.2.2 Phase II
8.2.2.1 Phase II market estimates and forecasts, 2017 - 2030 (USD Million)
8.3 Phase III
8.3.1 Phase III market estimates and forecasts, 2017 - 2030 (USD Million)
8.3.2 Phase IV
8.3.2.1 Phase IV market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 9. eClinical Solutions Market: End-use Analysis
9.1 End-use Business Analysis
9.2 Hospitals/Healthcare Providers
9.2.1 Hospitals market estimates and forecasts, 2017 - 2030 (USD Million)
9.2.2 Contract Research Organizations (CROs)
9.2.2.1 CROs market estimates and forecasts, 2017 - 2030 (USD Million)
9.3. Academic institutes
9.3.1 Academic institutes market estimates and forecasts, 2017 - 2030 (USD Million)
9.4 Pharma & biotech organizations
9.4.1 Pharma & biotech organizations market estimates and forecasts, 2017 - 2030 (USD Million)
9.5 Medical device manufacturers
9.5.1 Medical device manufacturers market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 10. eClinical Solutions Market: Regional Market Analysis, By Product, 2017 - 2030 (USD Million)
10.1 Definition & Scope
10.2 Regional Market Share Analysis, 2021& 2030
10.3 Regional Market Dashboard
10.4 Regional Market Snapshot
10.5 Regional Market Share and Leading Players, 2021
10.5.1 North America
10.5.2 Europe
10.5.3 Asia Pacific
10.5.4 Central & South America
10.5.5 MEA
10.6 Market Size, & Forecasts, and Trend Analysis, 2017 to 2030
10.6.1 North America
10.6.2 North America eClinical solutions market estimates and forecasts by countries, 2017 - 2030 (USD Million)
10.6.3 U.S.
10.6.3.1 U.S. eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.4 Canada
10.6.4.1 Canada eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.5 Mexico
10.6.5.1 Mexico eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.6 Europe
10.6.7 Europe eClinical solutions market estimates and forecasts by countries, 2017 - 2030 (USD Million)
10.6.8 U.K.
10.6.8.1 U.K. eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.9 Germany
10.6.9.1 Germany eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.10 France
10.6.10.1 France eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.11 Italy
10.6.11.1 Italy eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.12 Spain
10.6.12.1 Spain eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.13 Netherlands
10.6.13.1 Netherlands eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.14 Sweden
10.6.14.1 Sweden eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.15 Denmark
10.6.15.1 Denmark eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.16 Asia Pacific
10.6.17 Asia Pacific eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.18 Japan
10.6.18.1 Japan eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.19 China
10.6.19.1 China eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.20 India
10.6.20.1 India eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.21 South Korea
10.6.21.1 South Korea eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.22 Australia
10.6.22.1 Australia eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.23 New Zealand
10.6.23.1 New Zealand eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.24 Taiwan
10.6.24.1 Taiwan eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.25 Hong Kong
10.6.25.1 Hong Kong eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.26 Singapore
10.6.26.1 Singapore eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.27 Thailand
10.6.27.1 Thailand eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.28 Vietnam
10.6.28.1 Vietnam eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.29 Central & South America
10.6.30 Central & South America eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.31 Brazil
10.6.31.1 Brazil eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.32 Argentina
10.6.32.1 Argentina eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.33 Chile
10.6.33.1 Chile eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.34 MEA
10.6.35 MEA eClinical solutions market estimates and forecasts by countries, 2017- 2030 (USD MILLION)
10.6.36 South Africa
10.6.36.1 South Africa eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.37 Saudi Arabia
10.6.37.1 Saudi Arabia eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.38 United Arab Emirates
10.6.38.1 U.A.E. eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.39 Egypt
10.6.39.1 Egypt eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
10.6.40 Qatar
10.6.40.1 Qatar eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 11. Company Profiles
11.1 Oracle
11.1.1 Company Overview
11.1.2 Financial Performance
11.1.3 Product Benchmarking
11.1.4 Strategic Initiatives
11.2 PAREXEL International Corporation
11.2.1 Company Overview
11.2.2 Financial Performance
11.2.3 Product Benchmarking
11.2.4 Strategic Initiatives
11.3 Medidata Solution, Inc.
11.3.1 Company Overview
11.3.2 Financial Performance
11.3.3 Product Benchmarking
11.3.4 Strategic Initiatives
11.4 Bioclinica
11.4.1 Company Overview
11.4.2 Product Benchmarking
11.4.3 Strategic Initiatives
11.5 DATATRAK International, Inc.
11.5.1 Company Overview
11.5.2 Financial Performance
11.5.3 Product Benchmarking
11.5.4 Strategic Initiatives
11.6 CRF Health
11.6.1 Company Overview
11.6.2 Product Benchmarking
11.6.3 Strategic Initiatives
11.7 ERT Clinical
11.7.1 Company Overview
11.7.2 Product Benchmarking
11.7.3 Strategic Initiatives
11.8 eClinicalWorks
11.8.1 Company Overview
11.8.2 Product Benchmarking
11.8.3 Strategic Initiatives
11.9 IBM Watson Health
11.9.1 Company Overview
11.9.2 Product Benchmarking
11.9.3 Strategic Initiatives
11.10 OmniComm Systems, Inc. (Anju Software Inc.)
11.10.1 Company Overview
11.10.2 Financial Performance
11.10.3 Product Benchmarking
11.10.4 Strategic Initiatives
11.11 eClinical Solutions
11.11.1 Company Overview
11.11.2 Financial Performance
11.11.3 Product Benchmarking
11.11.4 Strategic Initiatives
11.12 Veeva Systems
11.12.1 Company Overview
11.12.2 Financial Performance
11.12.3 Product Benchmarking
11.12.4 Strategic Initiatives
Chapter 12. Recommendations/Conclusion